back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-12 13:29 Tx date 2026-06-10 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$17,500
+175,000 vol $0.10 each |
6,077,778 | |
| Filed 2026-06-12 13:28 Tx date 2026-06-10 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-17,500
-175,000 vol $0.10 each |
3,000,000 | |
| Filed 2026-04-30 13:04 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
5,902,778 | |
| Filed 2026-04-30 13:04 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
0 | |
| Filed 2026-04-23 15:51 Tx date 2026-04-20 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
3,175,000 | |
| Filed 2025-06-03 14:44 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
2,175,000 | |
| Filed 2025-05-01 15:54 Tx date 2025-04-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
5,402,778 | |
| Filed 2025-05-01 15:53 Tx date 2025-04-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
500,000 | |
| Filed 2025-03-20 11:51 Tx date 2025-02-07 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
4,902,778 | |
| Filed 2025-03-20 11:51 Tx date 2024-10-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
4,402,778 | |
| Filed 2025-02-11 13:02 Tx date 2025-02-07 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
||
| Filed 2024-10-30 16:26 Tx date 2024-10-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
||
| Filed 2025-02-11 13:02 Tx date 2025-02-07 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
2,075,000 | |
| Filed 2025-02-11 13:01 Tx date 2025-02-07 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
1,000,000 | |
| Filed 2024-10-30 16:26 Tx date 2024-10-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
1,575,000 | |
| Filed 2024-10-30 16:26 Tx date 2024-10-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
1,500,000 | |
| Filed 2024-07-30 10:45 Tx date 2024-07-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,000,000 vol |
2,000,000 | |
| Filed 2024-07-19 14:20 Tx date 2024-07-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,000,000 vol |
||
| Filed 2024-07-19 14:20 Tx date 2024-07-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,000,000 vol |
2,000,000 | |
| Filed 2024-07-19 14:19 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|